Home » FDA to Begin Benefit-Risk Assessment Pilot for Drug Reviews
FDA to Begin Benefit-Risk Assessment Pilot for Drug Reviews
The FDA plans to begin a pilot program putting a new benefit-risk framework to use in drug reviews as part of its efforts to bring more structure to the assessment system, an FDA official says.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May